Clinical Trials in Nanjin, China
1 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, China150 enrolled24 locationsNCT07152041
Recruiting
Phase 2Phase 3
Newly-diagnosed Pediatric T-cell ALL Protocol
Acute Lymphoblastic LeukemiaChildhood Leukemia, Acute LymphoblasticT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China610 enrolled27 locationsNCT06855810
Recruiting
Phase 3
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine222 enrolled9 locationsNCT05991908
Recruiting
Current Status of BTKi Treatment for CLL/SLL in China
CLL/SLL
The First Affiliated Hospital with Nanjing Medical University1,000 enrolled1 locationNCT06508684
Recruiting
Not Applicable
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
Chronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University89 enrolled1 locationNCT05950997
Recruiting
Phase 2
XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Xiaofeng Chen43 enrolled1 locationNCT06091423